April 2024
1. MURT A, Bayram B, Yilmaz U, Seyahi N, et al
   Chronic myeloid leukemia in renal transplantation patients in the era of tyrosine kinase inhibitors: A case report and review of the literature.
   Nephron. 2024 Apr 4. doi: 10.1159/000538532.
   

   >> Share

   
   March 2024
2. SAKASHITA M, Hamasaki Y, Oki R, Komaru Y, et al
   Serum myostatin at dialysis initiation may predict 1-year mortality and hospitalization.
   Nephron. 2024 Mar 23. doi: 10.1159/000538533.
   

   >> Share

   
   
3. WAND O, Drori I, Einbinder Y, Nacasch N, et al
   SARS CoV2 Omicron Infections Among Vaccinated Maintenance Hemodialysis Patients- outcomes and comparison to Delta variant.
   Nephron. 2024 Mar 14. doi: 10.1159/000536521.
   

   >> Share

   
   February 2024
4. MARSTRAND-JORGENSEN AB, Sembach FE, Bak ST, Ougaard M, et al
   Shared and distinct renal transcriptome signatures in three standard mouse models of chronic kidney disease.
   Nephron. 2024 Feb 14. doi: 10.1159/000535918.
   

   >> Share

   
   
5. OIKAWA M, Nishiwaki H, Hasegawa T, Sasaki S, et al
   The association between high-dose allopurinol and erythropoietin hyporesponsiveness in advanced chronic kidney disease. JOINT-KD study.
   Nephron. 2024 Feb 9. doi: 10.1159/000535874.
   

   >> Share

   
   December 2023
6. GUTIERREZ-PEREDO GB, Silva Martins MT, Albuquerque da Silva F, Barreto Lopes M, et al
   Self-reported fatigue by the Chalder fatigue questionnaire and mortality in Brazilian hemodialysis patients: The PROHEMO.
   Nephron. 2023 Dec 2. doi: 10.1159/000533472.
   

   >> Share

   
   November 2023
7. JEON YH, Lee SW, Jeon Y, Cho JH, et al
   The impact of C-reactive protein-to-albumin ratio on mortality in patients with acute kidney injury requiring continuous renal replacement therapy: A multicenter retrospective study.
   Nephron. 2023 Nov 29. doi: 10.1159/000534970.
   

   >> Share

   
   
8. YILMAZ S, Ozcakar ZB, Cakar N, Biral Coskun B, et al
   HOSPITALIZATIONS AFTER RENAL TRANSPLANTATION IN CHILDREN: RISK FACTORS, CAUSES AND OUTCOMES.
   Nephron. 2023 Nov 2. doi: 10.1159/000534787.
   

   >> Share

   
   October 2023
9. YAN Z, Shao T
   Chronic Inflammation in Chronic Kidney Disease.
   Nephron. 2023 Oct 18. doi: 10.1159/000534447.
   

   >> Share

   
   
10. HABERAL G, Yildirim T, Yilmaz SR, Altun B, et al
    CHRONIC KIDNEY DISEASE RISK IN LIVING KIDNEY TRANSPLANT DONORS: A LONG-TERM FOLLOW-UP STUDY.
    Nephron. 2023 Oct 3. doi: 10.1159/000534397.
    

    >> Share

    
    September 2023
11. YING M, Shao X, Qin H, Yin P, et al
    Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019.
    Nephron. 2023 Sep 15. doi: 10.1159/000534071.
    

    >> Share

    
    
12. NOWICKI M, Drozdz M, Wajda J, Klatko W, et al
    Continuous erythropoietin receptor activator for the treatment of chronic dialysis patients with renal anemia in daily clinical practice in Poland: A non-interventional, multi-center, pragmatic NAVIGO trial.
    Nephron. 2023 Sep 14. doi: 10.1159/000534070.
    

    >> Share

    
    
13. ZHANG Z, Liu P, Yang L, Zhao N, et al
    Association between the high-sensitivity C-reactive protein/albumin ratio on new-onset chronic kidney disease in Chinese individuals.
    Nephron. 2023 Sep 12. doi: 10.1159/000534034.
    

    >> Share

    
    August 2023
14. LUMLERTGUL N, Cameron LK, Bear DE, Ostermann M, et al
    Micronutrient Losses during Continuous Renal Replacement Therapy.
    Nephron. 2023 Aug 23:1-7. doi: 10.1159/000531947.
    

    >> Share

    
    
15. MORALES FEBLES R, Marrero Miranda D, Cruz Perera CC, Diaz Martin L, et al
    Therapeutic exercise on metabolic and renal outcomes in patients with Chronic Kidney Disease (CKD): A narrative review.
    Nephron. 2023 Aug 23. doi: 10.1159/000531921.
    

    >> Share

    
    
16. YOSHIKOSHI S, Yamamoto S, Suzuki Y, Imamura K, et al
    Association Between Physical Frailty and Sleep Disturbances Among Patients on Hemodialysis: A Cross-sectional Study.
    Nephron. 2023 Aug 16. doi: 10.1159/000533418.
    

    >> Share

    
    
17. ADRIAN T, Hornum M, Knop FK, Christensen KB, et al
    Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease.
    Nephron. 2023 Aug 16:1-12. doi: 10.1159/000531574.
    

    >> Share

    
    
18. HARA S
    The Chronology of Renal Allograft Dysfunction: The Pathological Perspectives.
    Nephron. 2023 Aug 11:1-7. doi: 10.1159/000531575.
    

    >> Share

    
    July 2023
19. LIU J, Zuo L, Walpen S, Bernard L, et al
    Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer carbonate in Chinese dialysis patients with hyperphosphataemia: A randomised, open-label, multicentre, 12-week phase III study.
    Nephron. 2023 Jul 20:1. doi: 10.1159/000531869.
    

    >> Share

    
    
20. PIKO N, Bevc S, Hojs R, Ekart R, et al
    Atherosclerosis and Epigenetic Modifications in Chronic Kidney Disease.
    Nephron. 2023 Jul 17:1-5. doi: 10.1159/000531292.
    

    >> Share

    
    
21. MILAN MANANI S, Mattiotti M, Marcello M, VIRZi GM, et al
    Contrast Induced Encephalopathy: a rare complication in a patient on Peritoneal Dialysis with several risk factors.
    Nephron. 2023 Jul 13. doi: 10.1159/000531771.
    

    >> Share

    
    
22. LIU J, Purtell L, Bonner A
    Kidney supportive care for working age adults with chronic kidney disease: A profile of characteristics and symptom burden.
    Nephron. 2023 Jul 10. doi: 10.1159/000531872.
    

    >> Share

    
    June 2023
23. HOJS R, Ekart R, Bevc S, Vodosek Hojs N, et al
    Chronic kidney disease and obesity.
    Nephron. 2023 Jun 2. doi: 10.1159/000531379.
    

    >> Share

    
    May 2023
24. FRAGALE G, Laham G, Raffaele P, Fortunato M, et al
    Renal transplantation in the elderly. Are they all the same? A multicenter, comorbidity based study.
    Nephron. 2023 May 25. doi: 10.1159/000531178.
    

    >> Share

    
    
25. JAMALE T, Kulkarni M, Keskar V
    What's wrong with the blood pressure target recommendation of KDIGO 2021 for hypertension in chronic kidney disease?
    Nephron. 2023 May 25. doi: 10.1159/000531029.
    

    >> Share

    
    
26. SHIMIZU T, Omoto K, Inui M, Nozaki T, et al
    Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation.
    Nephron. 2023 May 25. doi: 10.1159/000531177.
    

    >> Share

    
    
27. SAKA Y, Naruse T, Chikamatsu T, Mitani K, et al
    Long-term proton pump inhibitor therapy increases the risk of infection in patients with incident hemodialysis.
    Nephron. 2023 May 17:1. doi: 10.1159/000531028.
    

    >> Share

    
    
28. SANDOKJI I, Xu Y, Denburg M, Furth S, et al
    Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease.
    Nephron. 2023 May 15:1. doi: 10.1159/000530918.
    

    >> Share

    
    March 2023
29. BERNER T, Ferro C, Dieguez G, Metz S, et al
    Real-World Phosphate Binder Use Among Dialysis-Dependent Patients With CKD.
    Nephron. 2023 Mar 30. doi: 10.1159/000530230.
    

    >> Share

    
    
30. UZZO M, Moroni G, Ponticelli C
    Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease.
    Nephron. 2023 Mar 7:1-9. doi: 10.1159/000528243.
    

    >> Share

    
    February 2023
31. PREMARATHNE SS, Gamage C, Chandrajith R, Ratnatunge NV, et al
    Leptospirosis: A Potential Culprit for Chronic Kidney Disease of Uncertain Etiology.
    Nephron. 2023 Feb 21:1-10. doi: 10.1159/000528703.
    

    >> Share

    
    
32. KOBAYASHI A, Takeda A, Shinjo H, Iguchi D, et al
    Light chain deposition disease recurrence in renal allograft after long-term remission.
    Nephron. 2023 Feb 21. doi: 10.1159/000529776.
    

    >> Share

    
    January 2023
33. CHOU YH, Lai TS, Lin YC, Chiang WC, et al
    Age-Dependent Effects of Acute Kidney Injury on End-Stage Kidney Disease and Mortality in Patients with Moderate to Severe Chronic Kidney Disease.
    Nephron. 2023 Jan 17:1-8. doi: 10.1159/000528021.
    

    >> Share

    
    
34. ADRIAN T, Hornum M, Knop FK, Almdal T, et al
    Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease.
    Nephron. 2023 Jan 11:1-12. doi: 10.1159/000528080.
    

    >> Share

    
    
35. MIRIOGLU S, Kazancioglu R, Cebeci E, Eren N, et al
    Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study.
    Nephron. 2023 Jan 5:1-9. doi: 10.1159/000528170.
    

    >> Share

    
    
36. RHEE CM, You AS, Page V, Hayashida G, et al
    Racial and Ethnic Differences in Chronic Kidney Disease and Its Risk Factors among Asian-Americans and Pacific Islanders in Hawaii.
    Nephron. 2023 Jan 5:1-10. doi: 10.1159/000527990.
    

    >> Share

    
    
37. RODRIGUEZ-ESPINOSA D, Broseta JJ, Bastida C, Alvarez-Mora MI, et al
    Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment.
    Nephron. 2023;147.
    

    >> Share

    
    
38. TREVISANI F, Floris M, Cinque A, Bettiga A, et al
    Renal Histology in CKD Stages: Match or Mismatch with Glomerular Filtration Rate?
    Nephron. 2023;147:266-271.
    

    >> Share

    
    
39. GUO H, Bechtel-Walz W
    The Interplay of Autophagy and Oxidative Stress in the Kidney: What Do We Know?
    Nephron. 2023;147:627-642.
    

    >> Share

    
    
40. NONOYAMA S, Hotta K, Iwahara N, Tanabe T, et al
    Use of Mixed Lymphocyte Reaction Assay to Evaluate Immune Tolerance before Kidney Transplantation with an Immunosuppression-Free Protocol following Hematopoietic Stem Cell Transplantation from the Same Donor.
    Nephron. 2023;147:621-626.
    

    >> Share

    
    
41. ZHU M, Jiang L, Xu F, Hu J, et al
    Clinicopathological Characteristics and Outcomes of Renal Sarcoidosis: A Series Study of 18 Patients from a Single Center.
    Nephron. 2023;147:591-598.
    

    >> Share

    
    
42. KAWABE M, Yamamoto I
    Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation.
    Nephron. 2023;147 Suppl 1:9-13.
    

    >> Share

    
    November 2022
43. ZHAN Q, Zhao J, Guo Q, Niu J, et al
    Association of Sleep Duration with Physical Performance in Hemodialysis Patients: A Multicenter Cross-Sectional Study.
    Nephron. 2022 Nov 29:1-6. doi: 10.1159/000527406.
    

    >> Share

    
    October 2022
44. SENZAKI D, Yoshioka N, Nagakawa O, Inayama E, et al
    Modeling Low Muscle Mass Screening in Hemodialysis Patients.
    Nephron. 2022 Oct 21:1-9. doi: 10.1159/000526866.
    

    >> Share

    
    September 2022
45. OZTURK S, Gursu M, Arici M, Sahin I, et al
    Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkey.
    Nephron. 2022 Sep 30:1-9. doi: 10.1159/000526234.
    

    >> Share

    
    
46. KIMURA H, Yoshida S, Takeuchi M, Kawakami K, et al
    Impact of Potentially Inappropriate Medications on Kidney Function in Chronic Kidney Disease: Retrospective Cohort Study.
    Nephron. 2022 Sep 16:1-8. doi: 10.1159/000526326.
    

    >> Share

    
    July 2022
47. AGUR T, Zingerman B, Ben-Dor N, Alkeesh W, et al
    Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients.
    Nephron. 2022 Jul 27:1-8. doi: 10.1159/000525519.
    

    >> Share

    
    
48. CHARITAKI E, Damianakis N, Garbidaki A, Stamataki E, et al
    DPP4 Inhibitor-Induced Bullous Pemphigoid in Patients with Diabetes and Chronic Kidney Disease: Clinical Case Series.
    Nephron. 2022 Jul 18:1-6. doi: 10.1159/000525520.
    

    >> Share

    
    
49. BOMHOLT T, Kofod D, Norgaard K, Rossing P, et al
    Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Nephron. 2022 Jul 13:1-6. doi: 10.1159/000525676.
    

    >> Share

    
    May 2022
50. MURT A, Dinc HO, Altiparmak MR, Yalin SF, et al
    Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropositivity.
    Nephron. 2022 May 20:1-5. doi: 10.1159/000524658.
    

    >> Share

    
    April 2022
51. GUINAULT D, Bernier M, Delarche A, Neuville S, et al
    Immunogenicity of the BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis Is Associated with Medical Conditions.
    Nephron. 2022 Apr 27:1-6. doi: 10.1159/000524292.
    

    >> Share

    
    
52. ASH SR, Batlle D, Kendrick J, Oluwatosin Y, et al
    Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study.
    Nephron. 2022 Apr 22:1-11. doi: 10.1159/000523911.
    

    >> Share

    
    March 2022
53. KONN V, Motrapu M, Swiderska MK, Anders HJ, et al
    Drug Testing for Chronic Kidney Disease and Diabetes in Animals versus Humans: A Comparative Analysis of Study Designs and Reporting Qualities.
    Nephron. 2022 Mar 23:1-11. doi: 10.1159/000523666.
    

    >> Share

    
    February 2022
54. TODA A, Hara S, Tsuji H, Arase Y, et al
    Effects of Body Weight Change on Development of Chronic Kidney Disease in Obese Metabolic Phenotypes.
    Nephron. 2022 Feb 18:1-8. doi: 10.1159/000522159.
    

    >> Share

    
    
55. HAKAMAKI M, Jarvisalo MJ, Lankinen R, Koivuviita N, et al
    Evolution of Quality of Life in Chronic Kidney Disease Stage 4-5 Patients Transitioning to Dialysis and Transplantation.
    Nephron. 2022 Feb 9:1-10. doi: 10.1159/000521771.
    

    >> Share

    
    
56. SY J, Wenziger C, Marroquin M, Kalantar-Zadeh K, et al
    Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis.
    Nephron. 2022 Feb 4:1-9. doi: 10.1159/000521494.
    

    >> Share

    
    January 2022
57. KIDA N, Morishima T, Tsubakihara Y, Miyashiro I, et al
    Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative Data.
    Nephron. 2022 Jan 28:1-10. doi: 10.1159/000521603.
    

    >> Share

    
    
58. LEI Q, Xu F, Liang S, Liang D, et al
    Clinical Acute Kidney Injury and Histologic Acute Tubular-Interstitial Injury and Their Prognosis in Diabetic Nephropathy.
    Nephron. 2022;146:351-359.
    

    >> Share

    
    
59. JUNG J, Lee JH, Park YS
    Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
    Nephron. 2022;146:327-334.
    

    >> Share

    
    
60. SOOHOO M, Hashemi L, Hsiung JT, Moradi H, et al
    Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.
    Nephron. 2022;146:457-468.
    

    >> Share

    
    December 2021
61. OUYANG J, Bajracharya S, John S, Wagner J, et al
    Clotting of Hemodialysis Access in Patients with COVID-19 in an Inner-City Hospital.
    Nephron. 2021 Dec 20:1-6. doi: 10.1159/000520174.
    

    >> Share

    
    November 2021
62. PETNAK T, Thongprayoon C, Cheungpasitporn W, Shawwa K, et al
    The Prognostic Importance of Serum Sodium for Mortality among Critically Ill Patients Requiring Continuous Renal Replacement Therapy.
    Nephron. 2021 Nov 18:1-7. doi: 10.1159/000519686.
    

    >> Share

    
    
63. DONG X, Cao R, Li Q, Yin L, et al
    The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/beta-Catenin Signaling.
    Nephron. 2021 Nov 17:1-11. doi: 10.1159/000518756.
    

    >> Share

    
    
64. BOMHOLT T, Feldt-Rasmussen B, Butt R, Borg R, et al
    Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Nephron. 2021 Nov 3:1-7. doi: 10.1159/000519493.
    

    >> Share

    
    October 2021
65. BROGAN M, Ross MJ
    The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit.
    Nephron. 2021 Oct 11:1-5. doi: 10.1159/000519530.
    

    >> Share

    
    January 2021
66. HAKAMAKI M, Hellman T, Lankinen R, Koivuviita N, et al
    Elevated Troponin T and Enlarged Left Atrium Are Associated with the Incidence of Atrial Fibrillation in Patients with CKD Stage 4-5.
    Nephron. 2021;145:71-77.
    

    >> Share

    
    
67. DE VRIES BCS, Berger SP, Bakker SJL, de Borst MH, et al
    Pre-Transplant Plasma Potassium as a Potential Risk Factor for the Need of Early Hyperkalaemia Treatment after Kidney Transplantation: A Cohort Study.
    Nephron. 2021;145:63-70.
    

    >> Share

    
    
68. MORALES E, Galindo M, Trujillo H, Praga M, et al
    Update on Lupus Nephritis: Looking for a New Vision.
    Nephron. 2021;145:1-13.
    

    >> Share

    
    
69. MASAJTIS-ZAGAJEWSKA A, Pawlowicz E, Nowicki M
    Effect of Short-Term Cold Exposure on Central Aortic Blood Pressure in Patients with CKD.
    Nephron. 2021;145:20-26.
    

    >> Share

    
    
70. MOHAMMED A, Marie MA, Abdulazim DO, Hassan M, et al
    Serum Urate Lowering Therapy Using Allopurinol Improves Serum 25 Hydroxy Vitamin D in Stage 3-5 CKD Patients: A Pilot Study.
    Nephron. 2021;145:133-136.
    

    >> Share

    
    
71. KAIMORI JY, Mori T, Namba-Hamano T, Morimoto T, et al
    Cyclosporine A Treatment of Proteinuria in a New Case of MAFB-Associated Glomerulopathy without Extrarenal Involvement: A Case Report.
    Nephron. 2021;145:445-450.
    

    >> Share

    
    
72. KALANTAR-ZADEH K, Li PK, Tantisattamo E, Kumaraswami L, et al
    Living Well with Kidney Disease by Patient and Care-Partner Empowerment: Kidney Health for Everyone Everywhere.
    Nephron. 2021;145:205-211.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share